PP
EXAS

Paloma Partners’s Exact Sciences EXAS Stock Holding History

Paloma Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,700
Closed -$619K – 1907
2021
Q1 		$619K Buy
4,700
+3,900
+488% +$534K 0.01% 980
2020
Q4 		$106K Buy
+800
New +$96.7K ﹤0.01% 1506
2020
Q3 		– Sell
-1,600
Closed -$139K – 2192
2020
Q2 		$139K Buy
+1,600
New +$128K ﹤0.01% 1819
2019
Q4 		– Sell
-3,600
Closed -$325K – 2256
2019
Q3 		$325K Buy
+3,600
New +$410K 0.01% 1475
2019
Q2 		– Sell
-2,300
Closed -$199K – 1866
2019
Q1 		$199K Buy
+2,300
New +$196K ﹤0.01% 1525

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's EXAS Position: Q4 2024 in Review

Paloma Partners sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 6,834 shares — an estimated $466K sold.

Paloma Partners first reported a position in EXAS in Q3 2014 and held it in 18 quarters. The position peaked at $20.8M in Q2 2018. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Paloma Partners reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 6,834 Exact Sciences shares in Q4 2024, an estimated $466K.
  • Paloma Partners first reported a position in Exact Sciences in Q3 2014 and held it in 18 quarters.
  • Paloma Partners's Exact Sciences position peaked at $20.8M in Q2 2018.
  • 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.